Murugan Ramki (7 results)

Paperback. Condition: Brand New. 284 pages. 8.66x5.91x0.64 inches. In Stock.

Taschenbuch. Condition: Neu. Strategic Marketing for Indian Pharma SSIs to cope with Globalization | Murugan Ramki M. | Taschenbuch | 284 S. | Englisch | 2016 | LAP LAMBERT Academic Publishing | EAN 9783659916700 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.

paperback. Condition: New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -After the end of Process patent era in India by 2005 and in the product patent period Indian pharma industries have been challenged to compete with global organizations. Fortunately, India which has a unique strength of successful pharma companies which have the capacity to take up the challenge thanks to its reverse engineering process technology.Many Indian companies have the potential strength to innovate even many of the generics which still have the scope in world market and considered to be blockbusters after Product patent era. This study focuses on Indian Small Scale Pharma Companies as to what are 'the supposed to be' the strategic marketing decisions which enable these small scale manufacturing companies become game changers globally thereby paving a way to introduce a 'paradigm shift' approach for both prospective and existing pharma manufacturing entrepreneurs in India. 284 pp. Englisch.

Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Ramki M. MuruganStarted career with an MNC pharma company as an MSR and became an ASM in short time. After 9 years experience in sales & marketing, he became an entrepreneur in pharma industry. He had his MBA from TSM, Madurai and go.

Taschenbuch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -After the end of Process patent era in India by 2005 and in the product patent period Indian pharma industries have been challenged to compete with global organizations. Fortunately, India which has a unique strength of successful pharma companies which have the capacity to take up the challenge thanks to its reverse engineering process technology.Many Indian companies have the potential strength to innovate even many of the generics which still have the scope in world market and considered to be blockbusters after Product patent era. This study focuses on Indian Small Scale Pharma Companies as to what are 'the supposed to be' the strategic marketing decisions which enable these small scale manufacturing companies become game changers globally thereby paving a way to introduce a 'paradigm shift' approach for both prospective and existing pharma manufacturing entrepreneurs in India.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 284 pp. Englisch.

Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - After the end of Process patent era in India by 2005 and in the product patent period Indian pharma industries have been challenged to compete with global organizations. Fortunately, India which has a unique strength of successful pharma companies which have the capacity to take up the challenge thanks to its reverse engineering process technology.Many Indian companies have the potential strength to innovate even many of the generics which still have the scope in world market and considered to be blockbusters after Product patent era. This study focuses on Indian Small Scale Pharma Companies as to what are 'the supposed to be' the strategic marketing decisions which enable these small scale manufacturing companies become game changers globally thereby paving a way to introduce a 'paradigm shift' approach for both prospective and existing pharma manufacturing entrepreneurs in India.